Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes.

Huimin LiuHesong ZouDandan ShanWei LiuWenyang HuangWeiwei SuiShuhui DengTingyu WangRui LvMingwei FuYan XuShuhua YiGang AnYaozhong ZhaoLugui QiuDehui Zou

Published in: Cancer medicine (2024)

The GBM/GBC regimen is effective and well-tolerated, offering outcomes that are highly comparable to those in NHL patients conditioned with BEAM/BEAC, as demonstrated in a prognostically matched cohort.

Keyphrases

stem cell transplantation
high dose
ejection fraction
newly diagnosed
bone marrow
stem cells
prognostic factors
squamous cell carcinoma
metabolic syndrome
patient reported outcomes
cell therapy
adipose tissue
insulin resistance
locally advanced
chronic kidney disease
mesenchymal stem cells
glycemic control